Drug · DIN 02493241
BALVERSA
STARTER PACK
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since October 25, 2019.
- Drug Identification Number (DIN)
- 02493241
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Erdafitinib L01EN01
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERDAFITINIB | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 26, 2021: NOC 25583Supplement to a New Drug Submission (SNDS) · Safety update of the labelling
- October 25, 2019: NOC 22821New Drug Submission (NDS)
Other DINs named BALVERSA
- DIN 02493217 · Marketed
- DIN 02493225 · Marketed
- DIN 02493233 · Marketed